Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Glurenorm

Known as: Sanofi Synthelabo brand of gliquidone 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Immunohistochemical localization of islets of Langerhans of streptozotocin (65 mg/kg, ip) induced diabetic + glurenorm (10 mg/kg… Expand
  • table I
  • figure I
2005
2005
Oxidative stress plays an important role in chronic complications of diabetes mellitus, and hence the regulation of free radicals… Expand
2004
2004
SummaryGliquidone (Glurenorm) and glibenclamide were compared in a cross-over study of 20 non insulin dependent diabetics. Both… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • figure 2
2001
2001
The aim of this study was to investigate the effect of administering Glurenorm (gliquidone, 10 mg/kg) on the lenses and skins of… Expand
1997
1997
The duration of action and the pharmacokinetics of gliquidone (1-cyclohexyl-3-[[4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1, 3… Expand
1995
1995
The effectiveness of combined therapy with insulin and sulfonylurea in non-insulin dependent diabetes mellitus (NIDDM) patients… Expand
1993
1993
Due to its pharmacokinetics, glurenorm (95% of the drug metabolite is withdrawn from the body with the bile) is widely used in… Expand
1993
1993
Glurenorm, a IInd generation sulfanylurea preparation, was used for a year as a sugar-reducing drug in 20 patients with non… Expand
1993
1993
: Glurenorm, a IInd generation sulfanylurea preparation, was used for a year as a sugar-reducing drug in 20 patients with non… Expand
1992
1992
The authors evaluate treatment by a combination of insulin and gliquidone (Glurenorm) in 29 type 2 diabetics where long-term… Expand